VC  Prospect Venture Partners

     Office Locations:

525 University Ave., Suite 1350
Palo Alto, CA 94301
Phone: 650-327-8800
Fax: 650-324-8838



  • Early
  • Expansion
  • Growth
  • Seed



  • Life Sciences & Healthcare



    With $1 billion of capital under management, Prospect Venture Partners invests in biomedical technology and life science companies. Prospect seeks to ultimately invest $10-20 million in each company in its portfolio, typically as a lead investor or as a co-lead in an investor syndicate. The firm invests in companies with a broad range of development and financing requirements including: incubating new companies, investing in first and second venture financing rounds, and participating in later stage private and public companies (with proven business models requiring expansion capital). First round investments most often range from $500,000 to $10 million. The partners at Prospect Ventures have led investments in more than 50 companies and have an established track record of working closely with management teams in early and growth stage enterprises.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    David Schnell M.D. Managing Director and Co-Founder
    Russell Hirsch M.D., Ph.D. Managing Director


    Portfolio companies include:


    Recent News:

      There is no recent news for Prospect Venture Partners.